论文部分内容阅读
目的:研究痰热清注射液对中老年社区获得性肺炎患者C反应蛋白(CRP)的影响。方法:将100例中老年社区获得性肺炎患者随机分为治疗组和对照组,两组入院后均根据国家卫生部制定的社区获得性肺炎临床路径给予抗感染、止咳化痰治疗,治疗组加用痰热清注射液20mL,观察两组治疗前和治疗10d后血清C反应蛋白的变化情况。结果:两组患者经治10d后血清C反应蛋白均下降,但治疗组C反应蛋白下降更明显,两组之间的比较有统计学意义(P<0.05)。结论:痰热清注射液可明显降低社区获得性肺炎患者C反应蛋白,佐治社区获得性肺炎的疗效确切,联合用药可明显提高治疗效果。
Objective: To study the effect of Tanreqing injection on C-reactive protein (CRP) in community-acquired pneumonia in middle-aged and elderly people. Methods: A total of 100 middle-aged and elderly patients with community-acquired pneumonia were randomly divided into treatment group and control group. After admission, both groups were given anti-infective, cough and phlegm treatment according to the clinical path of community-acquired pneumonia developed by the Ministry of Health. With Tanreqing injection 20mL, observed two groups before treatment and after treatment 10d serum C-reactive protein changes. Results: Serum C-reactive protein decreased after treatment for 10 days in both groups, but the decrease of C-reactive protein in the treatment group was more obvious. The comparison between the two groups was statistically significant (P <0.05). Conclusion: Tanreqing Injection can significantly reduce the C-reactive protein in patients with community-acquired pneumonia, adjuvant community-acquired pneumonia curative effect is exact, combination therapy can significantly improve the therapeutic effect.